Table 1.
Sample description and differences between type 2 diabetes patients and healthy control participants.
| Type 2 diabetes patients (n = 74) | Healthy controls (n = 50) | p | |
|---|---|---|---|
| Gender | male: 46 (62.2%), female: 28 (37.8%) |
male: 30 (60.0%), female: 20 (40.0%) |
0.808 |
| Age (years) | 65.1 (8.2) | 63.4 (7.8) | 0.256 |
| School Education | 0.027 | ||
| <10 years of education | 23 (31.1%) | 5 (10.0%) | |
| 10 years of education | 19 (25.7%) | 12 (24.0%) | |
| >10 years of education | 29 (39.2%) | 31 (62.0%) | |
| Does not apply | 3 (4.1%) | 1 (2.0%) | |
| Marital Status | 0.619 | ||
| Single | 6 (8.1%) | 7 (14.0%) | |
| Married | 50 (67.6%) | 33 (66.0%) | |
| Divorced | 10 (13.5%) | 7 (14.0%) | |
| Widowed | 8 (10.8%) | 3 (6.0%) | |
| BMI | 30.2 (5.7) | 25.8 (3.5) | <0.001 |
| Illness duration | 13.3 (10.9) | ||
| Hba1c | 7.2 (1.1) | 5.5 (0.4) | <0.001 |
| Medication | |||
| Statins | 29 (39.2%) | ||
| Insulin | 21 (28.4%) | ||
| Other diabetic medication | 56 (75.3%) | ||
| Beta blockers | 18 (24.7%) | ||
| Other hypertensive medication | 28 (37.8%) | ||
| Lifetime MD | 26 (35.1%) | 11 (22.0%) | 0.138 |
Data are depicted as means (standard deviation) or n (percentage). Group differences were tested using t-test for continuous variables as well as chi2-tests for categorical variables. Other diabetic medication = metformin, sulfonylureas, GLP-1 receptor agonists, gliptins, gliflozins. Other hypertensive medication = ACE inhibitors, calcium channel blockers.